Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Safety and immunogenicity of an inactivated SARS-CoV-2 va... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
0
Authors
Shengli Xia
36 more
Shengli Xia
•
Shengli Xia
34 more
•
Xiaoming Yang
Published
October 15, 2020
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Infectious Diseases
Topics
Medicine
Immunology
Pathology
Internal Medicine
Infectious Diseases
Show all topics
DOI
10.1016/s1473-3099(20)30831-8
License
other-oa
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Infectious Diseases
Topics
Medicine
Immunology
Pathology
Internal Medicine
Infectious Diseases
Show all topics
DOI
10.1016/s1473-3099(20)30831-8
License
other-oa
